Jpmorgan Chase & Co - May 30, 2025 SCHEDULE 13G/A Report for Intra-Cellular Therapies, Inc. Common Stock, $0.0001 Par Value Per Share (ITCI)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Intra-Cellular Therapies, Inc. Common Stock, $0.0001 Par Value Per Share
Symbol: ITCI
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Date filed: 6/5/2025, 01:42 PM
Date of event: May 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	0%	0	0	0	Rachel Tsvaygoft	Vice President